A bipartisan attempt to cut prescription drug costs more than $100 billion passed out of Senate Finance Committee with the support of the U.S. Sen. Steve Daines.
The bill intended to save the Medicare program $85 billion and individuals $27 billion over 10 years passed on a 19-9 vote. Much of the savings comes from drug price caps. The savings estimate comes from the Congressional Budget Office.
The bill is known as the “Prescription Drug Pricing Reduction Act of 2019.”